CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $107,000 | +0.9% | 132,099 | 0.0% | 0.00% | – |
| Q4 2021 | $106,000 | -45.6% | 132,099 | -19.6% | 0.00% | – |
| Q3 2021 | $195,000 | -54.1% | 164,239 | -40.1% | 0.00% | – |
| Q2 2021 | $425,000 | -32.5% | 274,344 | +4.6% | 0.00% | – |
| Q1 2021 | $630,000 | +607.9% | 262,374 | +766.2% | 0.00% | – |
| Q4 2020 | $89,000 | +256.0% | 30,290 | +79.3% | 0.00% | – |
| Q1 2015 | $25,000 | -10.7% | 16,895 | -20.9% | 0.00% | – |
| Q4 2014 | $28,000 | -26.3% | 21,368 | 0.0% | 0.00% | – |
| Q3 2014 | $38,000 | – | 21,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |